Clinical Metagenomics in Infectious Disease Diagnostics

Clinical metagenomics harnesses high-throughput sequencing to profile all genetic material in a patient specimen, enabling the simultaneous detection of bacteria, viruses, fungi and parasites without prior assumptions. By applying shotgun sequencing or targeted capture panels to blood, respiratory secretions, cerebrospinal fluid or tissue biopsies, this approach delivers broad-spectrum pathogen identification, quantification of microbial load and insights into antimicrobial resistance determinants. Integration of host transcriptome analysis further refines diagnostic accuracy by distinguishing infectious from non-infectious inflammatory processes. Advances in library preparation, real-time analysis and cost reduction have accelerated turnaround times from days to hours, supporting rapid clinical decision-making in critical care and outbreak settings. Global surveillance efforts leverage metagenomic data to uncover emerging or divergent pathogens and to tailor public health interventions. Despite challenges in sensitivity at low pathogen titres, contamination control and standardisation of bioinformatics pipelines, metagenomics is poised to transform infectious disease diagnostics through its capacity for universal testing, precise antimicrobial stewardship and pandemic preemption.

Research from Nature Portfolio

Recent studies have demonstrated the power of unbiased metagenomic sequencing to resolve complex febrile illnesses in resource-limited settings. In a large cohort of patients presenting with unexplained fever, whole-sample sequencing identified multiple known and novel viruses, including divergent dicistroviruses and co-infecting pegiviruses associated with modulated disease severity. Real-time metagenomic analysis during outbreak investigations yielded rapid differential diagnoses—ranging from yellow fever and monkeypox to non-infectious causes—thereby informing targeted public health responses. This work underscores the feasibility of locally driven metagenomic workflows for accurate, real-time pathogen surveillance and differential diagnosis in high-burden regions.

Clinical Metagenomics in Infectious Disease Diagnostics publication trend

The graph below shows the total number of articles in clinical metagenomics in infectious disease diagnostics across all publications each year (not limited to Nature Index journals).

Technical terms

Shotgun metagenomic sequencing: Unbiased sequencing of all DNA in a sample to detect and quantify microbial species and resistance genes.

Metatranscriptome: The complete set of RNA transcripts in a sample, used to assess active microbial taxa and host gene expression.

Host transcriptome analysis: Profiling of human RNA to distinguish infectious from non-infectious inflammatory responses.

Targeted capture panel: A set of probes designed to enrich specific pathogen sequences, improving sensitivity for known organisms.

Taxonomic classifier: Bioinformatics software that assigns sequencing reads to microbial taxa based on reference databases.

Antimicrobial resistance gene detection: Identification of genetic markers conferring drug resistance through sequence analysis.

Oxford Nanopore Technologies (ONT): A sequencing platform that produces long reads in real time, enabling rapid on-site analysis.

Illumina sequencing: A short-read, high-throughput sequencing technology commonly used for comprehensive metagenomic profiling.

References

1. Metagenomic surveillance uncovers diverse and novel viral taxa in febrile patients from Nigeria. Nature Communications (2023).
2. Routine Metagenomics Service for ICU Patients with Respiratory Infection. American Journal of Respiratory and Critical Care Medicine (2024).
3. Evaluating metagenomics and targeted approaches for diagnosis and surveillance of viruses. Genome Medicine (2024).